Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Gross Profit: 2019-2025

Historic Gross Profit for Avidity Biosciences (RNA) over the last 7 years, with Sep 2025 value amounting to $12.5 million.

  • Avidity Biosciences' Gross Profit rose 434.03% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 106.27%. This contributed to the annual value of $10.9 million for FY2024, which is 13.99% up from last year.
  • As of Q3 2025, Avidity Biosciences' Gross Profit stood at $12.5 million, which was up 224.28% from $3.8 million recorded in Q2 2025.
  • Avidity Biosciences' 5-year Gross Profit high stood at $12.5 million for Q3 2025, and its period low was $1.6 million during Q1 2025.
  • For the 3-year period, Avidity Biosciences' Gross Profit averaged around $3.5 million, with its median value being $2.3 million (2024).
  • Within the past 5 years, the most significant YoY rise in Avidity Biosciences' Gross Profit was 434.03% (2025), while the steepest drop was 55.60% (2025).
  • Over the past 5 years, Avidity Biosciences' Gross Profit (Quarterly) stood at $1.9 million in 2021, then surged by 49.51% to $2.8 million in 2022, then dropped by 20.80% to $2.2 million in 2023, then spiked by 35.57% to $3.0 million in 2024, then skyrocketed by 434.03% to $12.5 million in 2025.
  • Its last three reported values are $12.5 million in Q3 2025, $3.8 million for Q2 2025, and $1.6 million during Q1 2025.